NIC96 Antibody

What is NIC96 and what is its structural composition?

NIC96 is a scaffold nucleoporin that forms part of the inner ring complex of the nuclear pore complex (NPC). Structurally, NIC96 consists of an elongated arrangement of 30 α-helices organized into three distinct modules: crown, trunk, and tail domains, conforming to the ancestral coatomer element 1 (ACE1) fold . The protein has dimensions that allow it to span significant portions of the NPC, with the N-terminus located in the center of the protein, which then zig-zags towards one end of the molecule. Helices α4–12 fold over themselves to form the crown of the ACE1 domain, with α6–9 running perpendicular to the trunk helices (α13–21). The C-terminal helices α22–30 form the tail module that extends at an angle from the trunk . This structural organization enables NIC96 to serve as a critical interaction hub in the nuclear pore complex.

How do NIC96 antibodies differ from nanobodies in research applications?

NIC96 antibodies are traditional polyclonal or monoclonal immunoglobulins that recognize specific epitopes on the NIC96 protein. In contrast, nanobodies are single-domain (VHH) antibody fragments derived from camelid heavy-chain-only antibodies. The key differences in research applications include:

The VHH-SAN12 nanobody specifically targets NIC96 between its trunk and tail modules, inserting its CDR loops 1 and 2 into the space between helices α20–21 and α22–25 . This specific binding capability makes nanobodies particularly valuable for structural studies and in vivo applications where traditional antibodies may be limited.

What is the functional significance of NIC96 within the nuclear pore complex?

NIC96 serves as a critical architectural element within the nuclear pore complex, contributing to both structural integrity and functional organization. Research indicates that:

• NIC96 is essential for NPC assembly and maintenance, providing a scaffold for other nucleoporins .

• The protein plays a key role in connecting different modules of the NPC, particularly linking components of the inner ring complex.

• NIC96's elongated structure enables it to reach across substantial distances within the NPC architecture.

• The protein displays conformational flexibility, with the potential to adopt different states, as evidenced by structural studies showing a ~19 Å shift between crown domains when bound by VHH-SAN12 nanobody .

• NIC96 contributes to the heterogeneity observed in NPC composition and size.

These properties make NIC96 a critical target for researchers studying nuclear transport mechanisms and NPC assembly dynamics.

How can I optimize immunofluorescence protocols using NIC96 antibodies?

When optimizing immunofluorescence protocols for NIC96 detection, consider the following methodological approaches:

• Fixation method selection: For nuclear pore proteins like NIC96, paraformaldehyde (4%) fixation for 15-20 minutes at room temperature generally preserves nuclear envelope structure while maintaining antibody epitope accessibility. For certain epitopes, methanol fixation (-20°C for 10 minutes) may better preserve antigenicity.

• Permeabilization optimization: Use 0.2-0.5% Triton X-100 for 5-10 minutes to ensure antibody access to the nuclear envelope without disrupting nuclear pore architecture. For some NIC96 epitopes, gentler permeabilization with 0.1% saponin may better preserve structural integrity.

• Blocking and antibody incubation: Use 5% BSA or 5-10% normal serum in PBS with 0.1% Triton X-100. For primary NIC96 antibody incubation, start with 1:100-1:500 dilution range and optimize through serial dilutions. Extended incubation (overnight at 4°C) often yields better signal-to-noise ratios compared to shorter incubations.

• Validation controls: Include samples treated with secondary antibody only to assess background, and if possible, NIC96-depleted cells as a negative control. Co-staining with antibodies against other nuclear pore components (such as those from the Y complex) can validate the specificity of NPC labeling .

• Confocal imaging settings: Use appropriate filter settings and acquire z-stacks (0.2-0.3 μm steps) to capture the complete nuclear envelope signal, followed by deconvolution if necessary.

These methodological approaches should be tailored based on the specific NIC96 antibody being used and the experimental question being addressed.

What techniques are effective for studying NIC96 conformational states using antibodies?

NIC96 exhibits conformational flexibility, making it a challenging but informative target for structural studies. Effective techniques include:

• Conformation-specific antibody generation: Immunize with specific NIC96 constructs representing distinct conformational states, such as the trunk-tail interface region where significant conformational changes have been documented .

• Nanobody complementation: Use nanobodies like VHH-SAN12 that recognize specific conformational epitopes. The VHH-SAN12 nanobody binds the interface between the trunk and tail modules of NIC96, causing a conformational shift that brings helices α20–21 and α22–25 closer together .

• FRET-based conformational sensors: Engineer FRET pairs into NIC96 at positions that change relative distance during conformational shifts, then use antibodies to immunoprecipitate specific conformers for quantitative analysis.

• Super-resolution microscopy: Combine NIC96 antibodies with techniques such as STORM or PALM to detect conformational heterogeneity at the single-molecule level within intact NPCs.

• Crosslinking mass spectrometry (XL-MS): Use chemical crosslinkers to capture NIC96 in different conformational states, followed by immunoprecipitation with conformation-specific antibodies and mass spectrometric analysis.

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Combine with immunocapture using conformation-specific antibodies to map dynamic regions of NIC96.

Evidence suggests that nanobody binding can stabilize specific NIC96 conformations, improving resolution in structural studies from 2.5 to 2.1 Å and allowing identification of previously unresolved structural elements, including helix α9 and two loops comprising 30 additional residues .

How can I use bio-layer interferometry (BLI) to characterize NIC96 antibody binding properties?

Bio-layer interferometry is an effective method for determining binding kinetics of antibodies to NIC96. A methodological approach based on research practices includes:

• Sensor preparation: Pre-incubate streptavidin biosensor tips in BLI buffer (10 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.1 mM EDTA, 0.05% Tween-20, 0.1% bovine serum albumin) for 10 minutes .

• Antibody immobilization: For biotinylated antibodies, immobilize to a response level of 0.2–0.5 nm over 40–60 seconds. For non-biotinylated antibodies, use an anti-Fc capture approach .

• Baseline establishment: Dip the coated biosensor tip in BLI buffer for at least 1 minute to establish a stable baseline .

• Association measurement: Measure association by exposing the antibody-coated tip to NIC96 protein at varying concentrations (typically a 3-5 fold dilution series starting at 10× the expected KD) for 1–80 minutes depending on kinetics .

• Dissociation measurement: Measure dissociation in BLI buffer for 1–220 minutes, adjusting based on observed dissociation rates .

• Data analysis: Fit the sensorgrams using global 1:1 kinetic binding parameters to determine kon, koff, and KD values. For nanobodies like VHH-SAN12 that bind NIC96, binding affinities in the nanomolar range have been observed .

This approach enables precise characterization of antibody-antigen interactions, providing critical information about specificity, affinity, and binding kinetics that inform experimental design.

How can I study NPC heterogeneity using NIC96 antibodies?

Nuclear pore complex heterogeneity is an emerging area of research, with evidence suggesting variations in composition and size . To investigate this phenomenon using NIC96 antibodies:

• Multiplex immunofluorescence: Combine NIC96 antibodies with antibodies against other nucleoporins using spectrally distinct fluorophores. Quantify co-localization patterns to identify NPC subpopulations. Different fluorescence intensities and patterns may indicate NPC heterogeneity.

• Super-resolution imaging: Apply STORM, PALM or STED microscopy with NIC96 antibodies to achieve nanometer-scale resolution of individual NPCs, enabling detection of structural variations not visible by conventional microscopy.

• Live-cell imaging with nanobodies: Express fluorescently-tagged anti-NIC96 nanobodies (like VHH-SAN12-mKate2) in cells. The formation of foci both on the nuclear envelope and in the cytoplasm/nucleus, while other nuclear pore markers show even distribution, suggests NPC heterogeneity .

• Proximity labeling approaches: Use antibodies to precipitate NIC96-containing complexes after BioID or APEX2 proximity labeling to identify differential protein associations in subpopulations of NPCs.

• Electron microscopy immunogold labeling: Quantify variations in NIC96 labeling density across the nuclear envelope using immunogold electron microscopy, which can reveal heterogeneity in NIC96 incorporation or accessibility.

• Cell cycle-specific analysis: Combine with cell cycle markers to determine if NPC heterogeneity correlates with cell cycle progression, potentially identifying assembly intermediates or specialized NPC subpopulations.

Research has shown that VHH-SAN12-mKate2 fusion proteins enriched at the nuclear envelope alongside Nup120-GFP, but formed distinct foci both on the nuclear envelope and within cells, while Nup120-GFP maintained even distribution . This suggests either that not all NPCs display NIC96 in an accessible conformation for VHH-SAN12 binding, or that there exists genuine heterogeneity in NIC96 presentation across the NPC population.

What approaches can resolve contradictions in NIC96 antibody binding data?

When faced with contradictory results from NIC96 antibody experiments, implement these methodological approaches:

• Epitope mapping: Determine the exact binding sites of different antibodies using techniques like:

  • Peptide arrays or SPOT synthesis

  • Hydrogen-deuterium exchange mass spectrometry (HDX-MS)

  • X-ray crystallography of antibody-antigen complexes

  • Deletion and point mutation analysis

• Conformational analysis: Assess whether contradictions stem from recognition of different NIC96 conformations:

  • Compare results with structural data showing NIC96 conformational flexibility

  • Consider that binding of nanobodies like VHH-SAN12 can induce conformational changes, bringing helices α20–21 and α22–25 closer together, resulting in a ~19 Å shift between crown domains

• Context-dependent accessibility: Evaluate whether the nuclear pore complex environment affects epitope accessibility:

  • Compare results from intact cells vs. isolated nuclear envelopes vs. purified proteins

  • Use proximity labeling approaches to determine which NIC96 regions are accessible in intact NPCs

• Antibody validation panel: Implement comprehensive validation:

  • Test antibodies in NIC96 knockout/knockdown systems

  • Perform immunoprecipitation with mass spectrometry to confirm specificity

  • Compare multiple antibodies targeting different NIC96 epitopes

• Quantitative analysis: Apply statistical methods to:

  • Normalize signals against appropriate controls

  • Account for expression level variations

  • Consider threshold effects in signal detection

Research has demonstrated that NIC96 exists in multiple conformational states, with structural alignment showing significant conformational shifts between different solved structures . This intrinsic flexibility may explain contradictory antibody binding results and highlights the importance of considering structural dynamics in experimental design and data interpretation.

How can NIC96 antibodies be used to study nuclear pore complex assembly?

Investigating nuclear pore complex assembly requires specialized methodological approaches where NIC96 antibodies can play crucial roles:

• Synchronized assembly systems:

  • In post-mitotic systems, monitor NIC96 incorporation during nuclear envelope reformation using time-lapse imaging with fluorescently-labeled antibodies or nanobodies

  • In interphase assembly, use systems like the Xenopus egg extract, adding labeled NIC96 antibodies to track incorporation into newly forming NPCs

• FRAP (Fluorescence Recovery After Photobleaching) with antibody fragments:

  • Express fluorescently-tagged anti-NIC96 nanobodies in cells

  • Photobleach a section of the nuclear envelope and measure recovery kinetics

  • Compare recovery rates between different nuclear pore components to determine assembly order

• Immunoprecipitation of assembly intermediates:

  • Use NIC96 antibodies to isolate assembly intermediates at different time points

  • Perform mass spectrometry to identify co-precipitating proteins

  • Construct assembly maps based on temporal association patterns

• Perturbation approaches:

  • Express nanobodies that bind specific regions of NIC96 in cells

  • Observe effects on NPC assembly and function

  • Research has shown that nanobodies like VHH-SAN1 can cause formation of puncta away from the nuclear envelope, potentially representing Y complexes that are slower to incorporate into NPC assembly

• Correlative light and electron microscopy (CLEM):

  • Use fluorescently-labeled NIC96 antibodies to identify assembly sites by light microscopy

  • Examine the same sites by electron microscopy to determine ultrastructural features

• In vitro reconstitution assays:

  • Use purified components to reconstitute NPC assembly steps

  • Apply NIC96 antibodies to block specific interaction surfaces

  • Monitor effects on assembly progression

Studies with nanobodies have revealed that the accessibility of different NIC96 epitopes varies during assembly, suggesting dynamic conformational changes during the process . The structural flexibility of NIC96, particularly at the interface between trunk and tail modules, may play a crucial role in accommodating the geometric constraints of NPC assembly.

What are the most effective validation strategies for NIC96 antibodies?

Rigorous validation is essential for ensuring reliable results with NIC96 antibodies. Implement these methodological approaches:

• Genetic validation:

  • Test antibody in NIC96 knockout/knockdown systems

  • For essential proteins like NIC96 where knockout is lethal, use degron-tagged systems for rapid depletion

  • Verify signal reduction/elimination in immunoblotting and immunofluorescence

• Cross-platform validation:

  • Compare antibody performance across multiple techniques (Western blot, immunofluorescence, immunoprecipitation)

  • Verify that size, localization, and interaction partners match expected patterns

  • For nanobodies, perform biolayer interferometry to confirm binding specificity and affinity

• Epitope confirmation:

  • Map the binding epitope using deletion constructs or peptide arrays

  • Verify epitope conservation across relevant species if cross-reactivity is claimed

  • For structural studies, determine antibody-antigen complex structures via X-ray crystallography, as done with NIC96-VHH-SAN12 complexes

• Orthogonal detection methods:

  • Compare antibody results with GFP-tagged NIC96 localization

  • Verify immunofluorescence patterns against RNA-FISH for NIC96 transcripts

  • Correlate with mass spectrometry quantification of NIC96 peptides

• Reproducibility assessment:

  • Test multiple antibody lots to ensure consistency

  • Compare results between independent antibodies targeting different NIC96 epitopes

  • Implement blinded analysis to eliminate bias in interpretation

Research has demonstrated that rigorous validation, including structural characterization of antibody-antigen complexes, provides valuable insights beyond mere validation, revealing conformational states and functional regions of NIC96 .

How can I troubleshoot non-specific binding with NIC96 antibodies?

Non-specific binding is a common challenge with nuclear pore complex proteins due to their abundance and the complex nuclear envelope environment. Address this methodologically:

• Optimization of blocking conditions:

  • Test different blocking agents (BSA, milk, normal serum, commercial blockers)

  • Increase blocking duration (2-16 hours) and concentration (3-10%)

  • Include additional blocking components (0.1-0.3% Triton X-100, 0.05-0.1% Tween-20, 100-200 mM glycine)

• Antibody dilution and incubation optimization:

  • Perform systematic dilution series to determine optimal concentration

  • Compare room temperature (1-2 hours) versus 4°C (overnight) incubation

  • Add low concentrations of detergents (0.05-0.1% Tween-20) to antibody diluent

• Cross-adsorption procedures:

  • Pre-adsorb antibodies against fixed cells lacking the target protein

  • For yeast studies, incubate antibodies with extracts from NIC96 mutant strains

  • For nanobodies, perform negative selection against related nucleoporins

• Affinity purification of antibodies:

  • Purify antibodies using recombinant NIC96 fragments

  • Elute under mild conditions to preserve antibody activity

  • Validate purified fractions by ELISA against NIC96 and potential cross-reactive antigens

• Alternative detection strategies:

  • Switch from polyclonal to monoclonal antibodies or highly specific nanobodies

  • Consider using highly-specific nanobodies like VHH-SAN12 that show nanomolar affinity for NIC96

  • Employ fragment antibodies (Fab) to reduce Fc-mediated background

Research using nanobodies has demonstrated that highly specific reagents can overcome many non-specific binding issues while providing additional structural and functional insights into NIC96 .

How do I interpret complex staining patterns with NIC96 antibodies?

Nuclear pore complex proteins often produce complex staining patterns reflecting their dynamic behavior and structural organization. Interpret these methodically:

• Pattern categorization and quantification:

  • Classify observed patterns (punctate nuclear rim, nucleoplasmic foci, cytoplasmic aggregates)

  • Quantify pattern distribution across cell populations

  • Track pattern changes in response to perturbations

• Colocalization analysis with known markers:

  • Compare with other nuclear pore components (e.g., Nup120-GFP)

  • Assess overlap with nuclear envelope markers (lamin, LBR)

  • Quantify colocalization using Pearson's or Mander's coefficients

• Temporal analysis:

  • Perform time-lapse imaging to track pattern dynamics

  • Correlate with cell cycle markers to identify cell cycle-dependent changes

  • Use pulse-chase approaches to distinguish newly synthesized from mature complexes

• Perturbation responses:

  • Evaluate pattern changes after nuclear transport inhibition

  • Assess effects of cytoskeletal disruption on NIC96 distribution

  • Compare patterns before and after stress treatments

• Structural context interpretation:

  • Consider NIC96's known conformational flexibility when interpreting heterogeneous patterns

  • Research has shown that VHH-SAN12-mKate2 fusion proteins form foci both on the nuclear envelope and in the cytoplasm/nucleus, while other NPC markers show even distribution

  • These observations suggest either NIC96 conformational heterogeneity or actual compositional differences between NPCs

• Resolution-matched analysis:

  • Use imaging modalities appropriate for the scale of observed features

  • Apply super-resolution techniques to resolve closely spaced NPCs

  • Consider the ~120 nm diameter of NPCs when interpreting clustered signals

Research with nanobodies targeting NIC96 has revealed unexpected heterogeneity in nuclear pore complex organization, with implications for understanding NPC assembly, maintenance, and functional diversity .

How can cryo-electron tomography be combined with NIC96 antibodies?

Cryo-electron tomography (cryo-ET) offers unprecedented insights into nuclear pore complex architecture when combined with NIC96 antibodies:

• Immunogold labeling for cryo-ET:

  • Optimize fixation protocols to maintain both antigenicity and ultrastructural preservation

  • Use small gold particles (2-5 nm) conjugated to anti-NIC96 antibodies or nanobodies

  • Apply correlation with fluorescence microscopy to identify regions of interest

• In situ structural determination:

  • Label NIC96 with nanobodies in cells prior to vitrification

  • Perform subtomogram averaging to generate high-resolution structures

  • Identify conformational states of NIC96 within intact NPCs

• Integrative structural biology approaches:

  • Combine cryo-ET data with crystal structures of NIC96-antibody complexes

  • Build composite models of NIC96 within the NPC architecture

  • Validate models using crosslinking mass spectrometry data

• Nanobody toolkits for multicolor cryo-ET:

  • Develop NIC96 nanobodies with different metal clusters or quantum dots

  • Use the established nanobody library, which includes VHH-SAN12 specifically targeting NIC96, as structural probes

  • Apply correlative light and electron microscopy to localize specific NIC96 conformations

• Time-resolved structural studies:

  • Capture NPC assembly intermediates by synchronizing cells

  • Vitrify at defined timepoints after mitosis

  • Label with NIC96 antibodies to track incorporation into nascent NPCs

Research has shown that nanobodies can aid in structural determination by stabilizing specific conformations of NIC96, as demonstrated by the improved resolution (from 2.5 to 2.1 Å) of NIC96 structures when bound to VHH-SAN12 . This approach could be extended to cryo-ET studies to resolve heterogeneity in NPC architecture.

What emerging single-molecule techniques can be applied with NIC96 antibodies?

Single-molecule approaches provide unique insights into NIC96 dynamics within the nuclear pore complex:

• Single-molecule localization microscopy (SMLM):

  • Use photoactivatable or photoswitchable fluorophore-conjugated NIC96 antibodies

  • Implement PALM or STORM imaging to achieve 10-20 nm resolution

  • Quantify NIC96 stoichiometry and spatial distribution within individual NPCs

• Single-particle tracking:

  • Label NIC96 with antibody fragments conjugated to quantum dots or organic dyes

  • Track movement of NIC96 molecules during NPC assembly or reorganization

  • Calculate diffusion coefficients and residence times in different NPC subdomains

• Single-molecule FRET (smFRET):

  • Use dual-labeled antibodies to detect conformational changes in NIC96

  • Monitor distance changes between labeled domains, particularly in the crown-trunk-tail interfaces where flexibility has been documented

  • Correlate conformational states with functional outcomes

• Optical tweezers combined with fluorescence:

  • Attach antibody-labeled microspheres to NIC96 exposed on isolated nuclear envelopes

  • Apply calibrated forces to measure mechanical properties of NIC96 linkages

  • Simultaneously monitor conformational changes using fluorescence

• Nanobody-based biosensors:

  • Engineer NIC96-binding nanobodies like VHH-SAN12 as conformational sensors

  • Incorporate environmentally-sensitive fluorophores at strategic positions

  • Monitor changes in fluorescence properties upon binding different NIC96 states

• Expansion microscopy with antibody retention:

  • Apply protein-retention expansion microscopy using NIC96 antibodies

  • Achieve effective sub-diffraction resolution with standard confocal microscopy

  • Map spatial relationships between NIC96 and other nucleoporins

Research has demonstrated the power of nanobodies in detecting NPC heterogeneity that was not apparent with traditional approaches . Single-molecule techniques can build on these observations to provide mechanistic insights into the functional significance of this heterogeneity.

How can artificial intelligence enhance NIC96 antibody image analysis?

Artificial intelligence approaches are transforming the analysis of complex nuclear pore complex images:

• Deep learning for pattern recognition:

  • Train convolutional neural networks (CNNs) on NIC96 immunofluorescence images

  • Automatically classify NPC distribution patterns and detect abnormalities

  • Identify subtle phenotypes not apparent to human observers

• Instance segmentation of nuclear pores:

  • Implement Mask R-CNN or similar architectures to identify individual NPCs

  • Measure fluorescence intensity, size, and morphology of each NPC

  • Track these parameters across experimental conditions

• Multi-channel correlation analysis:

  • Use deep learning to analyze co-localization patterns between NIC96 and other nucleoporins

  • Identify NPC subpopulations based on composition

  • Correlate compositional differences with functional outcomes

• Automated time-lapse analysis:

  • Train recurrent neural networks to track NPC dynamics over time

  • Predict assembly pathways based on temporal patterns

  • Identify critical timepoints for detailed investigation

• Super-resolution image enhancement:

  • Apply deep learning approaches (e.g., CARE, DeepSTORM) to enhance resolution of NIC96 antibody images

  • Generate super-resolved images from diffraction-limited data

  • Combine with experimental super-resolution for validation

• Generative models for structure prediction:

  • Train models on existing NIC96 structural data to predict conformations

  • Generate hypothetical structures under different conditions

  • Guide experimental design for validation of predicted states

• Cross-modality integration:

  • Develop AI tools to integrate data from light microscopy, electron microscopy, and structural biology

  • Create comprehensive models of NIC96 organization within the NPC

  • Identify discrepancies between models and experimental data for further investigation

Research has revealed complex patterns of NIC96 distribution, including the formation of foci both on the nuclear envelope and within cells when visualized with VHH-SAN12-mKate2 . AI-powered image analysis could help extract quantitative insights from these complex patterns and relate them to functional states of the nuclear pore complex.